GLYPAZE-MF

Glypaze-MF Tablet is an oral antidiabetic medication that combines Vildagliptin, a DPP-4 inhibitor, and Metformin, a biguanide. This dual-action combination helps improve glycemic control in adults with Type 2 Diabetes Mellitus, particularly when diet, exercise, and monotherapy are not sufficient. Glypaze-MF works by regulating insulin levels and lowering glucose production in the liver.

Key Benefits:

• Dual mechanism for better blood sugar control

• Vildagliptin enhances insulin secretion and reduces glucagon

• Metformin reduces hepatic glucose production and improves insulin sensitivity

• Helps maintain HbA1c targets over time

• Low risk of hypoglycemia when used appropriately